Viewing Study NCT02734160


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-01-08 @ 10:31 AM
Study NCT ID: NCT02734160
Status: COMPLETED
Last Update Posted: 2019-08-05
First Post: 2016-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module